Brain and Nervous System Cancer Clinical Trials
For more information about a clinical trial,
clinical trial eligibility, or informed consent,
contact our research nurses by phone or email:
Please Note: The eligibility criteria noted below are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any treatment to be undertaken must ultimately be determined on an individual basis by the patient and those involved in the patient's treatment. |
Brain Clinical Trials
| Study Title | ||||
|---|---|---|---|---|
| Body Location | Study # | Primary Investigator | More Info | |
Co-registered Fluorescence-Enhanced Resection of Malignant Glioma Phase I: Correlation with MR and Biopsy | ||||
| Brain and Nervous System | D0711 | Roberts | More Info | |
Multimodal Magnetic Resonance Protocol to Distinguish Tumor Recurrence From Treatment Related to Necrosis in Patients with High Grade Gliomas | ||||
| Brain and Nervous System | D0901 | Fadul | More Info | |
Cilengitide in subjects with newly diagnosed glioblastoma multiforme and methylated MGMT gene promoter¿a multicenter, open-label, controlled Phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment alone | ||||
| Brain and Nervous System | F0829 | Fadul | More Info | |
Phase 2 Study of Azixia for the Treatment of Patients with Recurrent Glioblastoma Multiforme | ||||
| Brain and Nervous System | F0859 | Fadul | More Info | |
Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma | ||||
| Brain and Nervous System | R0825 | Hartford | More Info | |
Phase 2 Study of Dose-Intense Temozolomide in Recurrent Glioblastoma (GBM) | ||||
| Brain and Nervous System | W0837 | Fadul | More Info | |
Immunologic Evaluation of Peripheral Blood | ||||
| Brain and Nervous System, Kidney, Melanoma, skin, Other Urinary, Urinary Bladder | D0229 | Ernstoff | More Info | |
A Randomized Phase 2 Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients | ||||
| Brain and Nervous System, Lung | F0817 | Fadul | More Info | |
